Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics

Schizophrenia Research

Volumn 50, Issue 1-2, 2001, Pages 95-103

  Meagher, David ^a,b   Quinn, John ^a   Murphy, Patrice ^c   Kinsella, Anthony ^d   Mullaney, James ^b   Waddington, John L ^a,e  

^a St Davnet's Hospital   (Ireland)

^b St Ita's Hospital   (Ireland)

^c St Loman's Hospital   (Ireland)

^d DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^e ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Factor structure; Initially unmedicated psychosis; Psychomotor poverty; Psychopathology; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEGATIVE SYNDROME; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RATING SCALE; SCHIZOPHRENIA;

AGED; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COGNITION DISORDERS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0035972732     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00050-5     Document Type: Article

References (44)

1. Symptoms of schizophrenia
2. Prospective clinicopathologic studies of schizophrenia: Accrual and assessment of patients
3. Establishing the onset of psychotic illness
4. Early intervention in schizophrenia
5. A randomised controlled trial of prophylactic neuroleptic treatment
6. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients
7. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?
8. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
9. 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician
10. Gender differences in the course of schizophrenia
11. Cognitive functioning in schizophrenia
12. Causes and consequences of the gender difference in age at onset of schizophrenia
13. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
14. First-episode schizophrenia. I. Early course parameters
15. Sex and schizophrenia
16. The symptoms of schizophrenia: A re-examination of the positive-negative dichotomy
17. Duration of psychosis and outcome in first-episode schizophrenia
18. Subtype progression and pathophysiologic deterioration in early schizophrenia
19. Frontal/executive impairments in schizophrenia
20. Factor structure of symptoms in functional psychoses
21. Gender differences in cognition in schizophrenia
22. Vulnerability to involuntary movements over a lifetime of severe schizophrenia approaches 100% in intimate association with frontal lobe dysfunction
23. Characterization of psychotic conditions
24. Bedside assessment of executive cognitive impairment: The executive interview
25. Executive impairment among the functionally dependent: Comparisons between schizophrenic and elderly subjects
26. Structure of schizophrenic symptomatology and its changes over time: Prospective factor-analytical study
27. The life course of schizophrenia: Age and symptom dimensions
28. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia
29. Executive (frontal) dysfunction and negative symptoms in schizophrenia: Apparent gender differences in 'static' vs 'progressive' profiles
30. Gender differences in the clinical expression of schizophrenia
31. Storage and executive processes in the frontal lobes
32. Executive functioning deficits in hypothetically psychosis-prone college students
33. Frontal leukotomy and related psychosurgical procedures in the era before antipsychotics (1935-1954): A historical overview
34. Course of treatment response in first-episode and chronic schizophrenia
35. Revisiting the factor structure for positive and negative symptoms: Evidence from a large heterogeneous group of psychiatric patients
36. Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia
37. Patterns of positive and negative symptoms in first episode schizophrenia
38. Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: Developmental origins and amelioration by antipsychotics?
39. The neurodevelopmental basis of schizophrenia: Clinical clues from cerebro-craniofacial dysmorphogenesis and the roots of a lifetime trajectory of disease
40. Neurodevelopmental and neuroprogressive processes in schizophrenia: Antithetical or complementary over a lifetime trajectory of disease?
41. Untreated psychosis and long-term outcome in schizophrenia
42. Developmental trajectory and disease progression in schizophrenia: The conundrum, and insights from a 12-year prospective study in the Monaghan 101
43. Schizophrenia: From neuropathology to neurodevelopment
44. Neuroleptics and the natural course of schizophrenia